See full prescribing information for IRESSA.<br/>IRESSA (gefitinib) tablets for oral use<br/>Initial U.S. Approval: 2015</title>

2015年7月13日 · IRESSA is an oral, EGFR tyrosine kinase inhibitor (TKI), which works by blocking the activity of the EGFR tyrosine kinase enzyme responsible for regulating signalling pathways implicated in the growth and survival of cancer cells. IRESSA was granted Orphan Drug Designation by the FDA in August 2014 for the treatment of EGFR mutation-positive NSCLC.

2024年11月26日 · Iressa is a cancer medication that interferes with the growth and spread of cancer cells in the body. Iressa is used to treat non-small cell lung cancer. Iressa is sometimes used to treat cancer that has spread to other parts of the body.

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances ...

2023年3月5日 · IRESSA is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Find patient medical information for Iressa oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

IRESSA is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies.

2023年5月17日 · Gefitinib (Iressa) is an EGFR inhibitor used to treat non-small cell lung cancer (NSCLC). It’s only used when the tumor has a specific mutation in the EGFR gene, which can be detected with a certain test. Gefitinib (Iressa) is convenient to take because you take it by mouth, but it can have some side effects such as acne-like rash and diarrhea.

2022年6月29日 · Iressa (gefitinib) is a tyrosine kinase inhibitor used for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test. What Are Side Effects of Iressa?

2020年2月16日 · What is Iressa used for? Iressa is used to treat lung cancer. If you are allergic to Iressa; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had. If you are breast-feeding. Do not …